From: Antiretroviral treatment reverses HIV-associated anemia in rural Tanzania
 |  |  | Crudea | Adjustedb | ||
---|---|---|---|---|---|---|
Variables | Total | Anemic after 12 months (%) | OR (95% CI) | P | OR (95% CI) | P |
Gender | Â | Â | Â | Â | Â | Â |
   Female | 75 | 30 (40.0) | 1 |  |  |  |
   Male | 27 | 9 (33.3) | 0.85 (0.33-2.20) | 0.744 |  |  |
Age (years) | Â | Â | Â | Â | Â | Â |
   <30 | 26 | 10 (38.5) | 1 |  |  |  |
   30-39 | 42 | 19 (45.2) | 1.45 (0.52-4.01) | 0.476 |  |  |
   ≥40 | 34 | 10 (29.4) | 0.77 (0.25-2.33) | 0.641 |  |  |
AIDSc | Â | Â | Â | Â | Â | Â |
   No | 41 | 16 (39.0) | 1 |  |  |  |
   Yes | 61 | 23 (37.7) | 0.93 (0.41-2.13) | 0.862 |  |  |
Tuberculosisd | Â | Â | Â | Â | Â | Â |
   No | 80 | 31 (38.8) | 1 |  |  |  |
   Yes | 22 | 8 (36.4) | 0.69 (0.24-1.94) | 0.477 |  |  |
BMI (kg/m2) | Â | Â | Â | Â | Â | Â |
   <16 | 26 | 9 (34.6) | 1 |  |  |  |
   16-18.4 | 35 | 15 (42.9) | 1.62 (0.55-4.78) | 0.382 |  |  |
   ≥18.5 | 40 | 14 (35.0) | 1.24 (0.42-3.64) | 0.702 |  |  |
MCV (fL) | Â | Â | Â | Â | Â | Â |
   ≥87.5 | 25 | 6 (24.0) | 1 |  | 1 |  |
   82.1-87.4 | 27 | 9 (33.3) | 1.47 (0.43-5.06) | 0.538 | 1.35 (0.38-4.72) | 0.644 |
   76.0-82.0 | 25 | 9 (36.0) | 1.75 (0.51-6.00) | 0.377 | 1.42 (0.39-5.13) | 0.595 |
   <76.0 | 25 | 15 (60.0) | 4.05 (1.17-14.1) | 0.028 | 4.34 (1.22-15.5) | 0.023 |
MCH (pg) | Â | Â | Â | Â | Â | Â |
   ≥28.1 | 26 | 7 (26.9) | 1 |  |  |  |
   26.6-28.0 | 24 | 7 (29.2) | 1.14 (0.33-3.95) | 0.841 |  |  |
   23.8-26.5 | 26 | 10 (38.5) | 1.70 (0.52-5.52) | 0.380 |  |  |
   <23.8 | 26 | 15 (57.7) | 3.20 (0.97-10.5) | 0.056 |  |  |
Initial regimen | Â | Â | Â | Â | Â | Â |
   Stavudine | 79 | 27 (34.2) | 1 |  | 1 |  |
   Zidovudine | 23 | 12 (52.2) | 2.46 (0.93-6.54) | 0.071 | 2.91 (1.03-8.19) | 0.043 |